Back
Adaptimmune Therapeutics PLC Vs. Biodexa Pharmaceuticals PLC Industry Stock Comparison
Sell
27
ADAP
Adaptimmune Therapeutics PLC
Last Price:
$0.28
Seasonality Move:
-12.65%
Sell
34
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
$0.85
Seasonality Move:
-11.97%
Sell
27
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
-
The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.28. The Score for ADAP is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy, Sell or Hold?
-
The current Biodexa Pharmaceuticals PLC [BDRX] share price is $0.85. The Score for BDRX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
BDRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.
BDRX Stock Price Chart
What is Biodexa Pharmaceuticals PLC's stock price today?
-
The Biodexa Pharmaceuticals PLC share price today is $0.85Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 56.25 | Buy |
Chaikin Money Flow: | 57505 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.25 - 0.27) | Buy |
Bollinger Bands (100): | (0.21 - 0.41) | Sell |
BDRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 40.74 | Sell |
Chaikin Money Flow: | 218413 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.83 - 1.01) | Sell |
Bollinger Bands (100): | (0.84 - 2.2) | Sell |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.27 | Buy |
20-day SMA: | 0.26 | Buy |
50-day SMA: | 0.27 | Buy |
200-day SMA: | 0.5 | Sell |
8-day EMA: | 0.27 | Buy |
20-day EMA: | 0.26 | Buy |
50-day EMA: | 0.27 | Buy |
200-day EMA: | 0.49 | Sell |
BDRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.88 | Sell |
20-day SMA: | 0.89 | Sell |
50-day SMA: | 1.08 | Sell |
200-day SMA: | 3.24 | Sell |
8-day EMA: | 0.88 | Sell |
20-day EMA: | 0.92 | Sell |
50-day EMA: | 1.13 | Sell |
200-day EMA: | 54.91 | Sell |
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.36 per share, and an increase next year of $0.01 per share.
Biodexa Pharmaceuticals PLC Earnings Growth & BDRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.04 per share.
Adaptimmune Therapeutics PLC Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biodexa Pharmaceuticals PLC Technical Analysis
Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |